RDD Pharma Ltd

Quick facts

Marketed products

• Oxymetazoline gel · Dermatology / Otolaryngology
  Oxymetazoline is a selective alpha-2 adrenergic receptor agonist that causes vasoconstriction of blood vessels in the nasal mucosa and skin.

Phase 1 pipeline

• Coated Nifedipine Suppositories
• Nifedipine coated suppositories
• Phenyephrine · Other

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• RDD Pharma Ltd portfolio CI brief
• RDD Pharma Ltd pipeline updates RSS